Publications by authors named "Yoon-Koo Kang"

100Publications

MAHOGANY: margetuximab combination in HER2 unresectable/metastatic gastric/gastroesophageal junction adenocarcinoma.

Future Oncol 2020 Dec 2. Epub 2020 Dec 2.

Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/fon-2020-1007DOI Listing
December 2020

Trends in Chemotherapy Patterns and Survival of Patients with Advanced Gastric Cancer Over a 16-year Period: Impact of Anti-HER2-Targeted Agent in the Real-World Setting.

Cancer Res Treat 2020 Oct 6. Epub 2020 Oct 6.

Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4143/crt.2020.725DOI Listing
October 2020

The role of novel fusion genes in human GIST cell lines derived from imatinib-resistant GIST patients: A therapeutic potential of fusion gene.

Biochem Biophys Res Commun 2020 Aug 18;529(3):699-706. Epub 2020 Jul 18.

Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, 05505, South Korea. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbrc.2020.05.174DOI Listing
August 2020

Impact of L-carnitine on imatinib-related muscle cramps in patients with gastrointestinal stromal tumor.

Invest New Drugs 2020 04 18;38(2):493-499. Epub 2019 Oct 18.

Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul, 05505, South Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10637-019-00860-xDOI Listing
April 2020

Association between the exposure to anti-angiogenic agents and tumour immune microenvironment in advanced gastrointestinal stromal tumours.

Br J Cancer 2019 11 14;121(10):819-826. Epub 2019 Oct 14.

Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41416-019-0596-1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6888806PMC
November 2019

Prognostic role of body composition parameters in gastric/gastroesophageal junction cancer patients from the EXPAND trial.

J Cachexia Sarcopenia Muscle 2020 02 28;11(1):135-144. Epub 2019 Aug 28.

1st Medical Department, University Cancer Center Leipzig (UCCL), University Leipzig Medical Center, Leipzig, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jcsm.12484DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7015239PMC
February 2020

Pharmacokinetic and exposure-response analysis of pertuzumab in patients with HER2-positive metastatic gastric or gastroesophageal junction cancer.

Cancer Chemother Pharmacol 2019 09 10;84(3):539-550. Epub 2019 Jun 10.

Clinical Pharmacology, Genentech Research and Early Development, DNA Way, MS463a, South San Francisco, CA, 94080, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-019-03871-wDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6682857PMC
September 2019

Intra-abdominal desmoid tumors mimicking gastrointestinal stromal tumors - 8 cases: A case report.

World J Gastroenterol 2019 Apr;25(16):2010-2018

Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, South Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3748/wjg.v25.i16.2010DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6487383PMC
April 2019

Phase II Trial of Continuous Regorafenib Dosing in Patients with Gastrointestinal Stromal Tumors After Failure of Imatinib and Sunitinib.

Oncologist 2019 11 29;24(11):e1212-e1218. Epub 2019 Apr 29.

Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2019-0033DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6853125PMC
November 2019

Perioperative FLOT: new standard for gastric cancer?

Lancet 2019 05 11;393(10184):1914-1916. Epub 2019 Apr 11.

Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, South Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0140-6736(18)33189-1DOI Listing
May 2019

Loss of HER2 positivity after anti-HER2 chemotherapy in HER2-positive gastric cancer patients: results of the GASTric cancer HER2 reassessment study 3 (GASTHER3).

Gastric Cancer 2019 05 1;22(3):527-535. Epub 2018 Nov 1.

Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-ro 43-gil, Songpa-gu, Seoul, 138-736, Republic of Korea.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s10120-018-0891-1
Publisher Site
http://dx.doi.org/10.1007/s10120-018-0891-1DOI Listing
May 2019

Prognostic impact of extranodal extension in stage 1B gastric carcinomas.

Surg Oncol 2018 Jun 8;27(2):299-305. Epub 2018 May 8.

Department of Surgery, University of Ulsan College of Medicine and Asan Medical Center, Seoul, 05505, South Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.suronc.2018.05.014DOI Listing
June 2018

Ultrasound-Guided Intraoperative Radiofrequency Ablation and Surgical Resection for Liver Metastasis from Malignant Gastrointestinal Stromal Tumors.

Korean J Radiol 2018 Jan-Feb;19(1):54-62. Epub 2018 Jan 2.

Department of Radiology, Asan Medical Center, Ulsan University College of Medicine, Seoul 05505, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3348/kjr.2018.19.1.54DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5768508PMC
November 2018

A Phase 1 Study of LY2874455, an Oral Selective pan-FGFR Inhibitor, in Patients with Advanced Cancer.

Target Oncol 2017 08;12(4):463-474

Division of Cancer Medicine, Peter MacCallum Cancer Centre, 305 Grattan St, Melbourne, VIC, 3000, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11523-017-0502-9DOI Listing
August 2017

Incidence of venous thromboembolism and the role of D-dimer as predictive marker in patients with advanced gastric cancer receiving chemotherapy: A prospective study.

World J Gastrointest Oncol 2017 Apr;9(4):176-183

Kwonoh Park, Medical Oncology and Hematology, Department of Internal medicine, Pusan National University Yangsan Hospital, Gyeongsangnam-do 50612, South Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4251/wjgo.v9.i4.176DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5390303PMC
April 2017

A Phase I/IIa Study of DHP107, a Novel Oral Paclitaxel Formulation, in Patients with Advanced Solid Tumors or Gastric Cancer.

Oncologist 2017 02 14;22(2):129-e8. Epub 2017 Feb 14.

Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2016-0273DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5330712PMC
February 2017

Objective response by mRECIST as a predictor and potential surrogate end-point of overall survival in advanced HCC.

J Hepatol 2017 06 26;66(6):1166-1172. Epub 2017 Jan 26.

Liver Cancer Translational Research Laboratory, BCLC Group, IDIBAPS, Liver Unit, Hospital Clinic, University of Barcelona, Barcelona, Catalonia, Spain; Liver Cancer Program, Division of Liver Diseases, Ichan School of Medicine at Mount Sinai, New York, NY, USA; Institució Catalana de Recerca i Estudis Avançats, Barcelona, Catalonia, Spain. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jhep.2017.01.012DOI Listing
June 2017

Anti-angiogenic Therapy in Patients with Advanced Gastric and Gastroesophageal Junction Cancer: A Systematic Review.

Cancer Res Treat 2017 Oct 3;49(4):851-868. Epub 2017 Jan 3.

Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4143/crt.2016.176DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5654167PMC
October 2017

Efficacy and safety of everolimus and sunitinib in patients with gastroenteropancreatic neuroendocrine tumor.

Cancer Chemother Pharmacol 2017 Jan 10;79(1):139-146. Epub 2016 Dec 10.

Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-ro 43-gil, Songpa-gu, Seoul, 138-736, South Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-016-3215-3DOI Listing
January 2017

A potential pitfall in evaluating HER2 immunohistochemistry for gastric signet ring cell carcinomas.

Pathology 2017 Jan 5;49(1):38-43. Epub 2016 Dec 5.

Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.pathol.2016.09.064DOI Listing
January 2017

Association of nutritional status-related indices and chemotherapy-induced adverse events in gastric cancer patients.

BMC Cancer 2016 11 18;16(1):900. Epub 2016 Nov 18.

Department of Food and Nutrition, Sookmyung Women's University, 100, Cheongpa-ro 47-gil, Yongsan-gu, Seoul, 04310, South Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12885-016-2934-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5116147PMC
November 2016

Role of transarterial chemoembolization in relation with sorafenib for patients with advanced hepatocellular carcinoma.

Oncotarget 2016 Nov;7(45):74303-74313

Department of Gastroenterology, Asan Liver Center, Asan Medical Center, University of Ulsan College of Medicine, Republic of Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.11030DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5342054PMC
November 2016

Regorafenib for the Treatment of Advanced Gastric Cancer (INTEGRATE): A Multinational Placebo-Controlled Phase II Trial.

J Clin Oncol 2016 08 20;34(23):2728-35. Epub 2016 Jun 20.

Nick Pavlakis, Niall C. Tebbutt, Lara R. Lipton, John R. Zalcberg, John Simes, and David Goldstein, Australasian Gastro-Intestinal Trials Group; Nick Pavlakis, Royal North Shore Hospital, University of Sydney; Katrin M. Sjoquist, Andrew J. Martin, Eric Tsobanis, Sonia Yip, and John Simes, National Health and Medical Research Council Clinical Trials Centre, University of Sydney; Katrin M. Sjoquist, Cancer Care Centre, St George Hospital; Sonia Yip, Sydney Catalyst Translational Cancer Research Centre; Mark Wong, Westmead Hospital; David Goldstein, Prince of Wales Hospital, Sydney, New South Wales; Niall C. Tebbutt, Austin Health; Lara R. Lipton, Western Health; Andrew Strickland, Monash Medical Centre; John R. Zalcberg, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia; Yoon-Koo Kang, Asan Medical Center, University of Ulsan College of Medicine; Yung-Jue Bang, Seoul National University Hospital; Sun Young Rha, Yonsei University College of Medicine; Jeeyun Lee, Samsung Medical Center, Sungkyunkwan University School of Medicine; Jae-Yong Cho, Gangnam Severance Cancer Hospital, Yonsei University College of Medicine, Seoul; Jin Won Kim, Seoul National University Bundang Hospital, Seongnam, South Korea; Thierry Alcindor, McGill University Health Centre, Montreal, Quebec; Christopher J. O'Callaghan, National Cancer Institute of Canada Clinical Trials Group, Kingston, Ontario; and Margot J. Burnell, Saint John Regional Hospital, Saint John, New Brunswick, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.65.1901DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5019744PMC
August 2016

Vorinostat in combination with capecitabine plus cisplatin as a first-line chemotherapy for patients with metastatic or unresectable gastric cancer: phase II study and biomarker analysis.

Br J Cancer 2016 May 12;114(11):1185-90. Epub 2016 May 12.

Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-ro 43-gil, Songpa-gu, Seoul 138-736, South Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/bjc.2016.125DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4891506PMC
May 2016

Integrative biomarker analyses indicate etiological variations in hepatocellular carcinoma.

J Hepatol 2016 08 27;65(2):296-304. Epub 2016 Apr 27.

Novartis Institutes for Biomedical Research, Cambridge, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jhep.2016.04.015DOI Listing
August 2016

Unmet needs of non-Hodgkin lymphoma survivors in Korea: prevalence, correlates, and associations with health-related quality of life.

Psychooncology 2017 03 13;26(3):330-336. Epub 2016 Apr 13.

Division of Hematology-Oncology, Inha University Hospital and College of Medicine, Incheon, South Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pon.4136DOI Listing
March 2017

Second-Line Irinotecan, Leucovorin, and 5-Fluorouracil for Gastric Cancer Patients after Failed Docetaxel and S-1.

Gastroenterol Res Pract 2016 29;2016:6857625. Epub 2015 Dec 29.

Department of Internal Medicine, Hallym University Medical Center, Hallym University College of Medicine, Anyang-si, Gyeonggi-do 14068, Republic of Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2016/6857625DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4709667PMC
February 2016

Associations between CYP2A6 polymorphisms and outcomes of adjuvant S-1 chemotherapy in patients with curatively resected gastric cancer.

Gastric Cancer 2017 Jan 29;20(1):146-155. Epub 2015 Dec 29.

Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-ro 43-gil, Songpa-gu, Seoul, 138-736, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10120-015-0586-9DOI Listing
January 2017

Impact of imatinib rechallenge on health-related quality of life in patients with TKI-refractory gastrointestinal stromal tumours: Sub-analysis of the placebo-controlled, randomised phase III trial (RIGHT).

Eur J Cancer 2016 Jan 14;52:201-8. Epub 2015 Dec 14.

Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2015.10.071DOI Listing
January 2016

Clinical and histopathologic analysis of 46 cases of cutaneous adverse reactions to imatinib.

Int J Dermatol 2016 May 18;55(5):e268-74. Epub 2015 Dec 18.

Department of Dermatology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ijd.13111DOI Listing
May 2016

Phase 2 study of adjuvant chemotherapy with docetaxel, capecitabine, and cisplatin in patients with curatively resected stage IIIB-IV gastric cancer.

Gastric Cancer 2017 Jan 11;20(1):182-189. Epub 2015 Dec 11.

Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-ro 43-gil, Songpa-gu, Seoul, 138-736, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10120-015-0580-2DOI Listing
January 2017

The standard diagnosis, treatment, and follow-up of gastrointestinal stromal tumors based on guidelines.

Gastric Cancer 2016 Jan 15;19(1):3-14. Epub 2015 Aug 15.

Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10120-015-0526-8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4688306PMC
January 2016

Efficacy of Imatinib in Patients with Platelet-Derived Growth Factor Receptor Alpha-Mutated Gastrointestinal Stromal Tumors.

Cancer Res Treat 2016 Apr 22;48(2):546-52. Epub 2015 Jun 22.

Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4143/crt.2015.015DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4843750PMC
April 2016

Phase II study of docetaxel, oxaliplatin, and S-1 therapy in patients with metastatic gastric cancer.

Gastric Cancer 2016 Apr 22;19(2):579-585. Epub 2015 May 22.

Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10120-015-0503-2DOI Listing
April 2016

FGFR2 Assessment in Gastric Cancer Using Quantitative Real-Time Polymerase Chain Reaction, Fluorescent In Situ Hybridization, and Immunohistochemistry.

Am J Clin Pathol 2015 Jun;143(6):865-72

Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Republic of Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1309/AJCPNFLSMWWPP8DRDOI Listing
June 2015

Successful control of heavily pretreated metastatic gastric cancer with the mTOR inhibitor everolimus (RAD001) in a patient with PIK3CA mutation and pS6 overexpression.

BMC Cancer 2015 Mar 13;15:119. Epub 2015 Mar 13.

Departments of Oncology, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul, 138-736, South Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12885-015-1139-7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4374284PMC
March 2015

Prognostic Relevance of p53 Overexpression in Gastrointestinal Stromal Tumors of the Small Intestine: Potential Implication for Adjuvant Treatment with Imatinib.

Ann Surg Oncol 2015 Dec 20;22 Suppl 3:S362-9. Epub 2015 Mar 20.

Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1245/s10434-015-4506-3DOI Listing
December 2015

Current Status and Challenges of Cancer Clinical Trials in Korea.

Cancer Res Treat 2016 Jan 2;48(1):20-7. Epub 2015 Mar 2.

Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4143/crt.2014.317DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4720073PMC
January 2016